According to the monthly return for the equity issuer, New Ray Medicine International Holding Limited (stock code: 06108) reported that, as of 28 February 2026, total authorized share capital stood at 15.00 billion ordinary shares with a par value of HKD 0.01 each, amounting to HKD 150.00 million. This figure remained unchanged compared to the previous month.

The total issued share capital (excluding treasury shares) was approximately 200.62 million ordinary shares, reflecting no change from the prior month. The applicable public float requirement was confirmed to be met. Additionally, 12.82 million share options remained outstanding, with no new shares issued under share options during the reporting period.

No other movements in shares or treasury shares were recorded, and no warrants, convertible securities, or other arrangements to issue new shares were disclosed in the document.